Genelux Corporation Stock Analysis & AI Score
Genelux Corporation (GNLX) has an ST Score of 28.3 (C-), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $17.33 price target (+613.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Genelux Corporation (GNLX) has an ST Score of 28.3 (C-), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $17.33 price target (+613.2% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- MomentumC+
- ValuationD+
- GrowthD
- Financial StrengthD-
- ProfitabilityF
- Piotroski2/9
Contact
GNLX stock: frequently asked questions
What is GNLX's ST Score?
Genelux Corporation (GNLX) has an ST Score of 28.3 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GNLX a buy, hold, or sell?
Analysts rate GNLX a Buy, with a price target of $17.33 (+613.2% vs the current price). Our ST Score grades it C- (28.3/100). The ST Score is a data-driven signal, not a recommendation.
What are GNLX's factor grades?
Valuation D+, Profitability F, Financial Strength D-, Momentum C+, Growth D, Forecast A.
What is GNLX's valuation grade?
Genelux Corporation (GNLX) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GNLX's growth grade?
Genelux Corporation (GNLX) earns a growth grade of D, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GNLX's profitability grade?
Genelux Corporation (GNLX) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GNLX's financial strength grade?
Genelux Corporation (GNLX) earns a financial strength grade of D-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GNLX?
The average analyst price target for Genelux Corporation (GNLX) is $17.33 from 3 analysts, which is +613.2% versus the recent price of $2.43.
What is GNLX's Piotroski score?
Genelux Corporation (GNLX) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.